Functional assessment of p53 in chronic lymphocytic leukemia.
about
CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humansDetection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia.Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approachAntibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion
P2860
Functional assessment of p53 in chronic lymphocytic leukemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Functional assessment of p53 in chronic lymphocytic leukemia.
@en
type
label
Functional assessment of p53 in chronic lymphocytic leukemia.
@en
prefLabel
Functional assessment of p53 in chronic lymphocytic leukemia.
@en
P2093
P2860
P50
P356
P1433
P1476
Functional assessment of p53 in chronic lymphocytic leukemia.
@en
P2093
L Ysebaert
M Brissard
M Le Garff-Tavernier
M Pannetier
P2860
P2888
P356
10.1038/BCJ.2011.3
P577
2011-02-25T00:00:00Z
P5875
P6179
1005061525